Shaoshui Chen

AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With <i>EGFR</i> Exon 19 Deletion or L858R Mutations

Shun Lü, Xiaorong Dong, Hong Jian et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial

Shun Lü, Qiming Wang, Guojun Zhang et al. · Journal of Thoracic Oncology · 2021 · 143 citations · Full text

Medicine, Oncology, Pharmacology +11

Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice

Fangfang Yang, Jingmin Li, Jin‐Hui Zhu et al. · European Journal of Pharmacology · 2015 · 99 citations

Medicine, Cancer Biology, Oncology +12

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4

Feng Wang, Mian-Li Li, Zeshun Yu et al. · Diagnostic Pathology · 2014 · 76 citations · Full text

Medicine, Oncology, Pharmacology +14

Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial

Zhigang Wei, Xia Yang, Xin Ye et al. · European Radiology · 2020 · 73 citations

Medicine, Oncology, Surgery +12